Prognostic Factors for Recovery from Sudden Sensorineural Hearing Loss: A Retrospective Study
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background and Objectives: This study aimed to investigate prognostic factors in patients with idiopathic sudden sensorineural hearing loss (ISSNHL). Subjects and Methods: From January 2007 to December 2011, a retrospective chart review identified 494 consecutive patients with ISSNHL. Demographic, audiometric, and clinical data were analyzed using a logistic regression test. Results: Hearing recovery from ISSNHL was significantly associated with factors such as age, duration from onset of symptoms to commencement of treatment, severity of the initial pure tone threshold, and the treatment method. Intratympanic (IT) steroid administration alone showed a comparable efficiency to oral steroid administration with or without IT steroid injection. In patients who received IT steroid injection, the duration from onset to treatment, severity of initial hearing loss, and sequential IT steroid injection following systemic steroid administration were statistically associated with hearing improvement. Conclusions: Age, severity of initial pure tone threshold, duration from onset to treatment, initial speech discrimination, and initial pure tone threshold are statistically significant prognostic factors related to hearing improvement in ISSNHL. IT steroid injection as an initial single treatment is comparable to systemic oral steroid administration.
Abstract
Background and Objectives: This study aimed to investigate prognostic factors in patients with idiopathic sudden sensorineural hearing loss (ISSNHL). Subjects and Methods: From January 2007 to December 2011, a retrospective chart review identified 494 consecutive patients with ISSNHL. Demographic, audiometric, and clinical data were analyzed using a logistic regression test. Results: Hearing recovery from ISSNHL was significantly associated with factors such as age, duration from onset of symptoms to commencement of treatment, severity of the initial pure tone threshold, and the treatment method. Intratympanic (IT) steroid administration alone showed a comparable efficiency to oral steroid administration with or without IT steroid injection. In patients who received IT steroid injection, the duration from onset to treatment, severity of initial hearing loss, and sequential IT steroid injection following systemic steroid administration were statistically associated with hearing improvement. Conclusions: Age, severity of initial pure tone threshold, duration from onset to treatment, initial speech discrimination, and initial pure tone threshold are statistically significant prognostic factors related to hearing improvement in ISSNHL. IT steroid injection as an initial single treatment is comparable to systemic oral steroid administration.
참고문헌 (32)
- 강우석, "돌발성 난청의 치료 원칙", 대한이비인후과학회지 두경부외과학, 54(10), pp.675~682 (2011), 대한이비인후과학회
- Wilson WR, "The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study", Arch Otolaryngol, 106, pp.772~776 (1980)
- Ahn JH, "Can intratympanic dexamethasone added to systemic steroids improve hearing outcome in patients with sudden deafness?", Laryngoscope, 118, pp.279~282 (2008)
- Byl FM Jr, "Sudden hearing loss: eight years’ experience and suggested prognostic table", Laryngoscope, 94, pp.647~661 (1984)
- Mattox DE, "Natural history of sudden sensorineural hearing loss", Ann Otol Rhinol Laryngol, 86, pp.463~480 (1977)
- Nosrati-Zarenoe R, "Idiopathic sudden sensorineural hearing loss: results drawn from the Swedish national database", Acta Otolaryngol, 127, pp.1168~1175 (2007)
- Kuhn M, "Sudden sensorineural hearing loss: a review of diagnosis, treatment, and prognosis", Trends Amplif, 15, pp.91~105 (2011)
- Lin CF, "Effect of comorbid diabetes and hypercholesterolemia on the prognosis of idiopathic sudden sensorineural hearing loss", Laryngoscope, 126, pp.142~149 (2016)
- Quaranta N, "High total cholesterol in peripheral blood correlates with poorer hearing recovery in idiopathic sudden sensorineural hearing loss", PLoS One, 10, pp.e0133300~ (2015)
- Ryu OH, "Hyperglycemia as a potential prognostic factor of idiopathic sudden sensorineural hearing loss", Otolaryngol Head Neck Surg, 150, pp.853~858 (2014)
- Hultcrantz E, "Corticosteroid treatment of idiopathic sudden sensorineural hearing loss: analysis of an RCT and material drawn from the Swedish national database", Eur Arch Otorhinolaryngol, 272, pp.3169~3175 (2015)
- Kim SH, "Comparison of steroid administration methods in patients with idiopathic sudden sensorineural hearing loss: a retrospective observational study", Clin Otolaryngol, 40, pp.183~190 (2015)
- Battaglia A, "A prospective, multi-centered study of the treatment of idiopathic sudden sensorineural hearing loss with combination therapy versus highdose prednisone alone: a 139 patient follow-up", Otol Neurotol, 35, pp.1091~1098 (2014)
- Siegel LG, "The treatment of idiopathic sudden sensorineural hearing loss", Otolaryngol Clin North Am, 8, pp.467~473 (1975)
- Nuttall AL, "Sound-induced cochlear ischemia", hypoxia as a mechanism of hearing loss, 1999, pp.2, 17~32
- Tabuchi K, "Ischemia-reperfusion injury of the cochlea: pharmacological strategies for cochlear protection and implications of glutamate and reactive oxygen species", Curr Neuropharmacol, 8, pp.128~134 (2010)
- Tabuchi K, "Outer hair cells functionally and structurally deteriorate during reperfusion", Hear Res, 173, pp.153~163 (2002)
- Liberman MC, "Hair cell condition and auditory nerve response in normal and noise-damaged cochleas", Acta Otolaryngol, 88, pp.161~176 (1979)
- Patuzzi RB, "Outer hair cell receptor current and sensorineural hearing loss", Hear Res, 42, pp.47~72 (1989)
- Wong AC, "Mechanisms of sensorineural cell damage, death and survival in the cochlea", Front Aging Neurosci, 7, pp.58~ (2015)
- Takumida M, "Age-dependent changes in the expression of klotho protein, TRPV5and TRPV6 in mouse inner ear", Acta Otolaryngol, 129, pp.1340~1350 (2009)
- Pauler M, "Correlative studies of cochlear neuronal loss with speech discrimination and pure-tone thresholds", Arch Otorhinolaryngol, 243, pp.200~206 (1986)
- Noguchi Y, "Delayed restoration of maximum speech discrimination scores in patients with idiopathic sudden sensorineural hearing loss", Auris Nasus Larynx, 43, pp.495~500 (2016)
- Fetterman BL, "Prognosis and treatment of sudden sensorineural hearing loss", Am J Otol, 17, pp.529~536 (1996)
- Li P, "Intratympanic methylprednisolone improves hearing function in refractory sudden sensorineural hearing loss: a control study", Audiol Neurootol, 16, pp.198~202 (2011)
- Lee JB, "The efficiency of intratympanic dexamethasone injection as a sequential treatment after initial systemic steroid therapy for sudden sensorineural hearing loss", Eur Arch Otorhinolaryngol, 268, pp.833~839 (2011)
- Rauch SD, "Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial", JAMA, 305, pp.2071~2079 (2011)
- Chou YF, "Comparison of intermittent intratympanic steroid injection and near-continual transtympanic steroid perfusion as salvage treatments for sudden sensorineural hearing loss", Laryngoscope, 123, pp.2264~2269 (2013)
- Suzuki H, "Hearing outcome does not depend on the interval of intratympanic steroid administration in idiopathic sudden sensorineural hearing loss", Eur Arch Otorhinolaryngol, 273, pp.3101~3107 (2016)
- Ohyama K, "Volume flow rate of perilymph in the guinea-pig cochlea", Hear Res, 35, pp.119~129 (1988)
- Salt AN, "Direct measurement of longitudinal endolymph flow rate in the guinea pig cochlea", Hear Res, 23, pp.141~151 (1986)
- Salt AN, "Perilymph pharmacokinetics of markers and dexamethasone applied and sampled at the lateral semi-circular canal", J Assoc Res Otolaryngol, 13, pp.771~783 (2012)